Search

everythinglearnresearchcommunity

for

Search:↓

Different types of sun exposure damage skin cells and immune cells, with chronic exposure leading to more severe and lasting damage.

Different types of sun exposure can damage skin cells and affect healing, with chronic exposure being more harmful, and certain immune cells help in the repair process.

Tacrolimus is effective for various skin conditions with fewer side effects than cyclosporine.

The document concludes that Cutaneous Lupus Erythematosus has different forms, is influenced by genetic and environmental factors, and can be treated with various medications, but more targeted therapies are needed.

FOXN1 gene variants cause low T cells and immune issues from birth.

Alopecia areata involves specific T-cells, unlike androgenetic alopecia.

T-cell reconstitution after thymus transplantation can cause hair whitening and loss.

New treatments targeting T-cell pathways are needed for better alopecia areata management.

T cells and bacteria in the gut and skin help maintain health and protect against disease.

Interferon alfa-2a is effective for treating cutaneous T cell lymphoma but has significant side effects.

An imbalance between certain immune cells is linked to a chronic skin condition and may be influenced by obesity, smoking, and autoimmune issues.

The document concludes that treatment for cutaneous T-cell lymphoma should be customized to each patient's disease stage, balancing benefits and side effects, with no cure but many patients living long lives.

Some patients with a type of skin lymphoma can experience a rare, non-scarring hair loss that looks like another hair loss condition but has distinct features.

The growth of the Epstein-Barr virus in the patient's cells was linked to the worsening of her lymphoma.

Blocking the CXCR3 receptor reduces T cell accumulation in the skin and prevents hair loss in mice.

Thymic transplantation normalized some T-cells but not others, maintaining immune function.

CD80CD86 deficiency causes hair loss by disrupting regulatory T cells.

A substance called miR-1246 may help treat severe hair loss by reducing certain immune cell activities.

CD3+ T-cell presence is a reliable marker to tell apart alopecia areata from pattern hair loss.

FoxN1 overexpression in young mice harms immune cell and skin development.

HTLV-1-associated lichenoid dermatitis (HALD) is linked to an immune response against HTLV-1-infected cells.

VDC-1101 shows potential as a treatment for canine cutaneous T-cell lymphoma.

Dandruff is linked to increased T cells and weakened immune protection in hair follicles.

Foxp3 is crucial for regulatory T cell function, and targeting these cells may help treat immune disorders.

Astilbin can potentially calm overactive immune responses, like in Type 1 Diabetes, by suppressing certain cell activities and reducing inflammation.

Immune cells affect hair growth and could lead to new hair loss treatments.

Stem cell offspring help control their parent stem cells, affecting tissue health, healing, and cancer.

People with HIV and low T cell counts have more hair and scalp problems.

Certain immune cells contribute to severe hair loss in chronic alopecia areata, with Th17 cells possibly having a bigger impact than cytotoxic T cells.

RANKL improves the immune response against herpes simplex virus by enhancing T cell activation and could help develop better treatments or vaccines.